Moreover, since the aim in clinical practice was to classify patients as early as possible, 230 patients with SLE (51.6%) with a disease duration of ≤2 years were identified in our cohort; 220 of them had positive ANA. Here, BTG3 is linked to systemic lupus erythematosus.